Inhibition of tumour cell growth by carnosine: some possible mechanisms

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Carnosine (β-alanyl-L-histidine) is a naturally occurring dipeptide.
• It selectively inhibits transformed cell growth.
• This inhibition is partly mediated by depleting glycolytic ATP levels.

Purpose of the Study:

• To explore the potential mechanisms by which carnosine suppresses glycolytic activity.
• To understand how carnosine reduces ATP supply and metabolic intermediates essential for cell reproduction.
• To investigate carnosine's potential as an endogenous "smart drug".

Main Methods:

• Theoretical discussion of probable and possible mechanisms.
• Review of existing literature on carnosine's biochemical effects.
• Analysis of carnosine's impact on cellular energy metabolism.

Main Results:

• Carnosine's inhibitory effects on transformed cells are linked to reduced ATP production via glycolysis.
• Potential mechanisms include effects on glycolytic enzymes, metabolic regulation, redox biology, protein glycation, glyoxalase activity, apoptosis, gene expression, and metastasis.
• Carnosine's pluripotent action suggests it may act as a targeted therapeutic agent.

Conclusions:

• Carnosine's ability to deplete ATP levels in transformed cells is a key mechanism of its anti-proliferative effect.
• Multiple pathways are likely involved in carnosine's action, highlighting its versatility.
• Carnosine shows promise as an endogenous "smart drug" for cancer therapy.